Home > Healthcare > Drug Device Combination > Therapeutic Systems > Flowable Hemostats Market

Flowable Hemostats Market Size

  • Report ID: GMI9238
  • Published Date: Apr 2024
  • Report Format: PDF

Flowable Hemostats Market Size

Flowable Hemostats Market size was valued at USD 723.8 million in 2023 and is anticipated to grow at a CAGR of 5.7% between 2024 and 2032. One of the primary drivers is the increasing number of surgeries and trauma cases, which has led to a higher demand for effective hemostatic agents to control bleeding.

 

Additionally, the rising prevalence of chronic diseases and the subsequent increase in surgical interventions have fueled the market growth. Further, the advancements in surgical techniques and the growing adoption of minimally invasive procedures have also contributed to the demand for flowable hemostats, as these products are often used to achieve hemostasis in such procedures. Furthermore, the development of innovative flowable hemostats with improved efficacy and safety profiles is also a significant factor contributing to market expansion.
 

Flowable hemostats are used to control bleeding during surgical procedures. They are typically delivered in a liquid or gel form and can be applied directly to the bleeding site. These hemostats work by promoting clot formation, which helps to seal off blood vessels and stop bleeding. Flowable hemostats are particularly useful in procedures where traditional methods such as sutures or pressure are not effective or feasible, such as in minimally invasive surgeries or surgeries involving delicate tissues.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Flowable hemostats industry size recorded USD 723.8 million in 2023 and will exhibit a 5.7% CAGR between 2024 and 2032 due to increasing surgical procedures, the rising prevalence of chronic diseases and traumatic injuries and technological advancements.

The orthopedic surgery segment registered 18.6% flowable hemostats industry share in 2023, driven by rising prevalence of orthopedic conditions, advancements in surgical techniques and the development of specialized hemostatic products.

North America flowable hemostats industry will record 5.4% CAGR up to 2032, owing to advanced healthcare infrastructure, high prevalence rates of chronic diseases requiring surgical interventions, and significant investments in research and development.

Major players operating in the flowable hemostats industry are 3D Matrix Medical Technology, Aegis Lifesciences Private Limited, Baxter International Inc., CR Bard Inc. (Becton, Dickinson, and Company), Ethicon, Inc. (Johnson & Johnson), Ferrosan Medical Devices A/S, Pfizer, Inc., and Teleflex Incorporated are among others.

Flowable Hemostats Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 10
  • Tables & Figures: 210
  • Countries covered: 22
  • Pages: 117
 Download Free Sample